Unfinished Business: How do we end HIV?
28 Jan 2026 | 3 – 4pm GMT | 10 – 11am EST
Of the 40 million people living with HIV, nearly a quarter are not receiving life-saving treatment and new transmissions are not falling as fast as many experts hope. So how can the world meet the UN’s target of ending the HIV epidemic by 2030?
Join New Scientist’s panel of experts in a roundtable discussion examining the future of HIV care and the collective efforts required to end the epidemic.
Panellists:
Dr. Joseph Eron is a professor of medicine and Chief of the Division of Infectious Diseases, University of North Carolina at Chapel Hill
Dr. Sally Hodder is professor of medicine, director of the West Virginia Clinical and Translational Science Institute, and associate vice president for clinical and translational research at West Virginia University.
Dr. Kimberly Smith is senior vice president, chief scientific officer, and head of research and development at ViiV Healthcare, where she oversees the clinical development of meaningful advances in treatment and care for people living with HIV
Dr. Babafemi Taiwo is vice president and head of early development at ViiV Healthcare where he spearheads the development of cutting-edge treatments for people impacted by HIV
Justin Mullins (chair) is a consultant editor at New Scientist
This free event is being run and funded by ViiV Healthcare.
Read more about this topic in our Feature Article here: Unfinished business: ending the HIV epidemic
